Endocrine Late Effects after Cancer Therapy (ELECT) Program

Cancer treatments in children, including chemotherapy, radiation, and immunotherapy, can cause endocrine problems in over half of patients. These problems include growth disorders, difficulties with puberty, thyroid issues, development of diabetes mellitus, and poor bone health. Endocrine disorders due to cancer therapy can occur any time, from immediately to many years later. As cancer survival rates have improved, treatment-related endocrine disorders have become even more common.

The Endocrine Late Effects after Cancer Therapy (ELECT) Program at Children's Hospital of Philadelphia (CHOP) is a team with expertise in identifying and treating endocrine disorders due to cancer therapy. Children who develop endocrine complications following cancer treatment are not the same as children with other endocrine problems, and so CHOP has an endocrine team with expertise in this unique patient population.

Our Team

The ELECT Program includes pediatric endocrinologists and a dual-certified pediatric oncologist/endocrinologist who have demonstrated expertise in the endocrine late effects of cancer treatment.